Pune, India, October, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on In Vivo Imaging Market Research Report
The global in vivo imaging market is presumed to register a significant CAGR during the forecast period (2017-2023) owing to the increasing prevalence of cancer, asserts Market Research Future (MRFR). In vivo imaging can be referred to the visualization of various life processes in an organism. Any abnormality prevailing in the biological system can be diagnosed as the presence of disease. It involves the studying the interaction of cells with biomarkers, radioisotopes, irradiations with electromagnetic radiations or luminescent proteins. It facilitates the early detection of biological abnormalities and helps to curb the ill effects.
Drivers and Restraints Impacting the Market
With the increasing expenditure on healthcare and growing prevalence of cancer, the global market for in vivo imaging is likely to propel during the review period. Research and development activities in the imaging technology for diagnosing several types of chronic diseases such as cancer is further augmenting the market growth. Additionally, the growing incidences of chronic diseases have inflicted a fear among the population has increased the need for frequent checkup, thereby augmenting the demand for in vivo imaging. The increasing number of clinical research organizations and pharmaceutical companies along with rising application of in vivo imaging in real-time data storage, pre-clinical research, and high-resolution modalities are some of the key growth factors of the market.
On the flip side, lack of awareness about in vivo imaging, low expenditure on healthcare in developing countries, and uneven distribution of medical services over regional boundaries are likely to retard the market growth in the coming years.
Global In Vivo Imaging Market: Segmental Analysis
The global in vivo imaging market has been segmented on the basis of application, end-users, techniques, and region.
By mode of application, the global in vivo imaging market has been segmented into optical imaging, nuclear imaging, and others.
By mode of techniques, the global in vivo imaging market has been segmented into biomarkers based, radioisotopes based, luminescent proteins-based techniques, and others.
By mode of end-users, the global in vivo imaging market has been segmented into imaging centers, hospitals and clinics, research organizations, and others.
Geographically, the in vivo imaging market span across regions namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Among all the regions, America holds the largest market share due to the growing prevalence of chronic diseases such as cancer. Also, the presence of developed countries like Canada and the U.S. is likely to augment the market growth in this region.
Europe is estimated to hold the second position in the market due to factors such as growing expenditure on healthcare. Moreover, rapid technological advancements in the healthcare services are anticipated to boost the market growth during the assessment period.
The Asia Pacific region is considered to grow rapidly during the assessment period owing to the presence of developing economies such as China and India which are adopting the latest technologies in the medical sectors. On the other hand, the Middle East and Africa are estimated to show the least growth due to low penetration of the region in the market. Moreover, factors such as low per capita income and lack of awareness regarding in vivo imaging are considered to inhibit the market growth in this region.
October 2, 2018: A team of scientists at the University of Tsukuba has developed a tool that is capable of imaging the development of atherosclerotic plaque in the body and can follow its progression. This enables the accurate evaluation of drugs in order to treat atherosclerosis and analyze the risk posed by such plaque in an individual.
The major players operating the global market are Aspect Imaging., MR Solutions, New England Biolabs, Mediso Ltd., MILabs B.V., LI-COR, Inc., FUJIFILM VisualSonics Inc., Biospace Lab S.A., Bruker, and TRIFOIL IMAGING